In the morning of July 30, 2018, Dr. Ming-Wei Wang (Director, The National Center for Drug Screening/Chinese National Compound Library and Dean, School of Pharmacy, Fudan University) met with Dr. Hui Li (Vice President of Business Development and General Manager of China Operations, Sorrento Therapeutics, Inc., NASDAQ: SRNE; Expert of China’s Thousand Talent Program) at San Diego, California, USA. They conducted a productive discussion relative to forging bilateral and multilateral collaborations in cell therapy technology platform.